Home › UPDATE 2-FDA advisers recommend against Delcath's cancer therapy
 

Keywords :   


UPDATE 2-FDA advisers recommend against Delcath's cancer therapy

2013-05-03 20:54:18| Biotech - Topix.net

A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer therapy for a rare form of eye cancer that spreads to the liver, saying it was too risky.

Tags: update recommend cancer therapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Is social media worth paying for?
12.05Switzer Ranch staying resilient with long-term outlook
12.05BIF announces Seedstock, Commercial Producer award finalists
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
11.05YouGov Unveils Americans Skincare Routines
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
More »